A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

por McLaughlin, Ronan P., He, Jichao, van der Noord, Vera E., Redel, Jevin, Foekens, John A., Martens, John W. M., Smid, Marcel, Zhang, Yinghui, van de Water, Bob
Publicado 2019